000 00945 a2200301 4500
005 20250518034725.0
264 0 _c20191128
008 201911s 0 0 eng d
022 _a1759-4782
024 7 _a10.1038/s41571-019-0215-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBradley, Conor A
245 0 0 _aPerioperative FLOT superior to ECF/X.
_h[electronic resource]
260 _bNature reviews. Clinical oncology
_c08 2019
300 _a465 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAdenocarcinoma
650 0 4 _aCapecitabine
650 0 4 _aCisplatin
650 0 4 _aDocetaxel
650 0 4 _aEpirubicin
650 0 4 _aFluorouracil
650 0 4 _aHumans
650 0 4 _aLeucovorin
650 0 4 _aOxaliplatin
773 0 _tNature reviews. Clinical oncology
_gvol. 16
_gno. 8
_gp. 465
856 4 0 _uhttps://doi.org/10.1038/s41571-019-0215-3
_zAvailable from publisher's website
999 _c29622173
_d29622173